Restaging after chemoradiotherapy for locally advanced esophageal cancer

Restaging after chemoradiotherapy (CRT) for locally advanced esophageal cancer is a pivotal part of modern treatment individualization. de Gouw et al. performed a systematic review and meta-analysis determining the value of different modalities for the locoregional part of restaging, involving response assessment of the primary tumor and regional lymph nodes (1). Detection of potentially emerged distant metastasis is the other crucial part of restaging after CRT.